A federal judge ruled that Envigo can finalize the sales for 500 of its remaining 3,000 research dogs, but it needs to improve the safety and health of the animals remaining at its facilities while federal officials decide their fate.

A new program will provide 150 early-career scientists committed to advancing diversity, inclusion, and equity up to $8.6 million each.

Researchers report they were able to make functional sperm in a dish, a feat previously only possible for mice.

An analysis of scientists’ networks finds discrepancies in the diffusion of novel ideas through communities.

Thomas Stoeger of Northwestern University has previously studied scientists’ limited focus on certain genes. In a new study, he shows how these same behaviors extend into the science of COVID-19.

A study finds improvement in the proportion of scientific projects that include both sexes, but analyzing results by sex is not routine.

Staff at the UK’s Harwell Institute were notified that a strategy board recommended halting its academic work, but a final decision is months away.

A drive for revenue is damaging basic science.

Despite the Human Genome Project having heralded the exploration of previously unknown human genes, the focus of genetic studies remains narrow.

With multiple applications in biomedicine, the antibodies can now be made quickly, cheaply, and without the need for an alpaca or one of its relatives.

Nineteen researchers have stepped down after the journal decided not to retract a paper that they say plagiarized the work of a Johns Hopkins biomedical scientist.

Mentoring is critical for students just beginning to learn the ropes of biomedical research.

The Scripps Research Institute will join forces with the California Institute for Biomedical Research.

It is unethical to admit increasing numbers of students to graduate programs without considering the realities of the job market.

Following an independent group’s finding of misreported outcomes, the Annals of Internal Medicine now requires that authors include clinical trial protocols when submitting their results.

Study reveals trends in the frequency of female first authors on medical studies.

The nonprofit institution names a new CEO and president.

Despite dramatic increases in publications, the last 50 years have seen relatively little return on investment for US public health, a study suggests.